Fetal Death: Clinical Trials

2 trials for Fetal Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 2

Follow Fetal Death: new trials by email Literature Review of Fetal Death trials Research Report on Fetal Death

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT), Artemether-lumefantrine (AL) - Malaria,Falciparum, Malaria in Pregnancy
Phase 4Active not recruitingDuke University21742023-11-062026-10-30
Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali
Azithromycin to pregnant women, Azithromycin to infants, Placebo to pregnant women - Stillbirths and Infant Mortality
Phase 4Active not recruitingUniversity of Maryland, Baltimore997002020-09-242026-08-07

Narrower conditions

Stillbirth (2)  ·  Infant Death (1)  ·  Malaria, Falciparum (1)  ·  Premature Birth (1)

Broader conditions

Death (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Infections (1)  ·  Malaria (1)  ·  Mosquito-Borne Diseases (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Vector Borne Diseases (1)

Interventions

Artemether, Lumefantrine Drug Combination (1)

Sponsors

Duke University (1)  ·  University of Maryland, Baltimore (1)

Countries

Democratic Republic of the Congo (1)  ·  Kenya (1)  ·  Mali (1)

Top investigators

Karen L Kotloff, MD (1)  ·  Steve M Taylor, MD, MPH (1)

Results publications

PMID 37648393

NIH funding

U01AI162463 (1)